MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202631075250 A) filed by Dr. Shankar Prasad Sha; Dr. Shivanand M Gotyal; Mahendran Botlagunta; Dr. Samta Shukla; Dr. Gudipudi Kishore; Jagdish Satish Giri; Suparna Deepak; Aabaka Sreenath Reddy; Dr. Nagamani Je; and Dr. Sailaja C S on June 17, 2026, for Gut Microbiota Analysis System For Immunity And Metabolic Disorder Assessment.
Inventors include Dr. Shankar Prasad Sha; Dr. Shivanand M Gotyal; Mahendran Botlagunta; Dr. Samta Shukla; Dr. Gudipudi Kishore; Jagdish Satish Giri; Suparna Deepak; Aabaka Sreenath Reddy; Dr. Nagamani Je; and Dr. Sailaja C S.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present invention discloses an artificial intelligence enabled gut microbiota analysis system configured for assessing immunity status and metabolic disorder risks through comprehensive microbiome analysis. The system acquires microbiome related biological data from biological samples and processes microbial composition information, abundance patterns, diversity characteristics, and functional pathway parameters using advanced computational techniques. An artificial intelligence analysis engine analyzes microbiome features in association with immune response indicators and metabolic health parameters to identify microbial signatures related to immune modulation and metabolic disorders. The system generates personalized assessment outputs comprising immunity profiles, microbial imbalance indicators, and metabolic risk predictions. The invention further integrates clinical, biological, and lifestyle parameters to enhance predictive accuracy and enables continuous monitoring of microbiome variations for personalized healthcare management and early identification of potential health risks.
Disclaimer: Curated by HT Syndication.
